Calmare Therapeutics (CTTC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2013 | 12-2012 | 09-2012 | 06-2012 | 03-2012 | |
| Sales | 62 | 255 | 334 | 123 | 358 |
| Cost of Goods | 360 | -1,041 | 378 | 547 | 482 |
| Gross Profit | -298 | 1,296 | -44 | -425 | -124 |
| Operating Expenses | 834 | 1,855 | 896 | 1,066 | 1,121 |
| Operating Income | -772 | -599 | -563 | -943 | -763 |
| Interest Expense | 33 | 42 | 19 | 13 | 10 |
| Other Income | 23 | -29 | -16 | 14 | -23 |
| Pre-tax Income | -782 | -670 | -597 | -942 | -795 |
| Net Income Continuous | -782 | -670 | -597 | -942 | -795 |
| Net Income | $-782 | $-670 | $-597 | $-942 | $-795 |
| EPS Basic Total Ops | -0.05 | -0.05 | -0.04 | -0.06 | -0.05 |
| EPS Basic Continuous Ops | -0.05 | -0.04 | -0.04 | -0.06 | -0.05 |
| EPS Diluted Total Ops | -0.05 | -0.05 | -0.04 | -0.06 | -0.05 |
| EPS Diluted Continuous Ops | -0.05 | -0.04 | -0.04 | -0.06 | -0.05 |
| EBITDA(a) | $-770 | $-596 | $-559 | $-939 | $-759 |